Surgery for Intravenous Leiomyomatosis

Surgical Management of Intravenous Leiomyomatosis With Intracardiac Extension: Our Experience and Outcomes

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01707862

Acronym

SIVL

Enrollment

Registered

2012-10-16

Start date

1997-03-31

Completion date

2012-10-31

Last updated

2012-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Leiomyomatosis

Keywords

Intravenous leiomyomatosis, Surgery, Smooth muscle tumor

Brief summary

Intravenous leiomyomatosis (IVL) with intracardiac extension is a rare benign smooth muscle tumor. Reviewing literature, intracardiac extension of the IVL has been reported in at least 70 cases. Most are individual case reports. Surgical experience is not much. However, different opinion of surgical strategies remain controversial. The purpose of this report is to describe our experience of surgical management for the IVL with intracardiac extension.

Detailed description

All patients underwent surgical management. Clinical data were obtained from medical reports. Following-up was made through email and telephone.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

FEMALE

Age

18 Years to 80 Years

Healthy volunteers

Yes

Inclusion criteria

* Age more than 18 years. * Tumor markers were all within normal limits. * Patients underwent surgical management. * Patients were followed-up for more than 12 months.

Exclusion criteria

-Tumor markers were all within abnormal limits

Countries

China

Outcome results